Matches in SemOpenAlex for { <https://semopenalex.org/work/W4298629750> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4298629750 endingPage "iv17" @default.
- W4298629750 startingPage "iv16" @default.
- W4298629750 abstract "Abstract AIMS MGMT methylation in glioblastoma predicts response to temozolomide but dichotomizing methylation status may mask the true prognostic value of quantitative MGMT methylation. This study evaluated whether extent of MGMT methylation interacts with the effect of temozolomide on overall survival. METHOD We included consecutive glioblastoma patients aged ≥16 years diagnosed (April 2012–May 2020) at a neuro-oncology center. All patients had quantitative MGMT methylation measured using pyrosequencing. Those with MGMT methylated tumors were stratified into high and low methylation groups based on a cut-off using Youden index on 2-year survival. Our accelerated failure time survival models included extent of MGMT methylation, age, postoperative Karnofsky performance score, extent of resection, temozolomide regimen, and radiotherapy. RESULTS There were 414 patients. Optimal cut-off point using Youden index was 25.9% MGMT methylation. The number of patients in the unmethylated, low and high methylation groups was 223 (53.9%), 81 (19.6%), and 110 (26.6%), respectively. In the adjusted model, high (hazard ratio [HR] 0.60, 95% confidence intervals [CI] 0.46– 0.79, P=0.005) and low (HR 0.67, 95% CI 0.50–0.89, P<0.001) methylation groups had better survival compared to unmethylated group. There was no evidence for interaction between MGMT methylation and completed temozolomide regimen (interaction term for low methylation P=0.097; high methylation P=0.071). This suggests no strong effect of MGMT status on survival in patients completing temozolomide regimen. In patients not completing the temozolomide regimen, higher MGMT methylation predicted better survival (interaction terms P<0.001). CONCLUSION Quantitative MGMT methylation may provide additional prognostic value. This is important when assessing clinical and research therapies." @default.
- W4298629750 created "2022-10-02" @default.
- W4298629750 creator A5016950249 @default.
- W4298629750 creator A5020693613 @default.
- W4298629750 creator A5021827141 @default.
- W4298629750 creator A5028897120 @default.
- W4298629750 creator A5040705186 @default.
- W4298629750 creator A5064572493 @default.
- W4298629750 creator A5067858634 @default.
- W4298629750 creator A5091893743 @default.
- W4298629750 date "2022-10-01" @default.
- W4298629750 modified "2023-10-03" @default.
- W4298629750 title "Extent of MGMT Promoter Methylation Modifies the Effect of Temozolomide on Overall Survival in Patients with Glioblastoma: A Regional Cohort Study" @default.
- W4298629750 doi "https://doi.org/10.1093/neuonc/noac200.073" @default.
- W4298629750 hasPublicationYear "2022" @default.
- W4298629750 type Work @default.
- W4298629750 citedByCount "0" @default.
- W4298629750 crossrefType "journal-article" @default.
- W4298629750 hasAuthorship W4298629750A5016950249 @default.
- W4298629750 hasAuthorship W4298629750A5020693613 @default.
- W4298629750 hasAuthorship W4298629750A5021827141 @default.
- W4298629750 hasAuthorship W4298629750A5028897120 @default.
- W4298629750 hasAuthorship W4298629750A5040705186 @default.
- W4298629750 hasAuthorship W4298629750A5064572493 @default.
- W4298629750 hasAuthorship W4298629750A5067858634 @default.
- W4298629750 hasAuthorship W4298629750A5091893743 @default.
- W4298629750 hasBestOaLocation W42986297501 @default.
- W4298629750 hasConcept C104317684 @default.
- W4298629750 hasConcept C126322002 @default.
- W4298629750 hasConcept C143998085 @default.
- W4298629750 hasConcept C150194340 @default.
- W4298629750 hasConcept C190727270 @default.
- W4298629750 hasConcept C207103383 @default.
- W4298629750 hasConcept C2776694085 @default.
- W4298629750 hasConcept C2777389519 @default.
- W4298629750 hasConcept C2779527866 @default.
- W4298629750 hasConcept C2781413609 @default.
- W4298629750 hasConcept C33288867 @default.
- W4298629750 hasConcept C44249647 @default.
- W4298629750 hasConcept C54355233 @default.
- W4298629750 hasConcept C71924100 @default.
- W4298629750 hasConcept C86803240 @default.
- W4298629750 hasConcept C91965660 @default.
- W4298629750 hasConceptScore W4298629750C104317684 @default.
- W4298629750 hasConceptScore W4298629750C126322002 @default.
- W4298629750 hasConceptScore W4298629750C143998085 @default.
- W4298629750 hasConceptScore W4298629750C150194340 @default.
- W4298629750 hasConceptScore W4298629750C190727270 @default.
- W4298629750 hasConceptScore W4298629750C207103383 @default.
- W4298629750 hasConceptScore W4298629750C2776694085 @default.
- W4298629750 hasConceptScore W4298629750C2777389519 @default.
- W4298629750 hasConceptScore W4298629750C2779527866 @default.
- W4298629750 hasConceptScore W4298629750C2781413609 @default.
- W4298629750 hasConceptScore W4298629750C33288867 @default.
- W4298629750 hasConceptScore W4298629750C44249647 @default.
- W4298629750 hasConceptScore W4298629750C54355233 @default.
- W4298629750 hasConceptScore W4298629750C71924100 @default.
- W4298629750 hasConceptScore W4298629750C86803240 @default.
- W4298629750 hasConceptScore W4298629750C91965660 @default.
- W4298629750 hasIssue "Supplement_4" @default.
- W4298629750 hasLocation W42986297501 @default.
- W4298629750 hasLocation W42986297502 @default.
- W4298629750 hasOpenAccess W4298629750 @default.
- W4298629750 hasPrimaryLocation W42986297501 @default.
- W4298629750 hasRelatedWork W1511534472 @default.
- W4298629750 hasRelatedWork W1987028324 @default.
- W4298629750 hasRelatedWork W1995740954 @default.
- W4298629750 hasRelatedWork W1998472924 @default.
- W4298629750 hasRelatedWork W2012946111 @default.
- W4298629750 hasRelatedWork W2053722981 @default.
- W4298629750 hasRelatedWork W2129558754 @default.
- W4298629750 hasRelatedWork W2335501790 @default.
- W4298629750 hasRelatedWork W2914412605 @default.
- W4298629750 hasRelatedWork W3154887287 @default.
- W4298629750 hasVolume "24" @default.
- W4298629750 isParatext "false" @default.
- W4298629750 isRetracted "false" @default.
- W4298629750 workType "article" @default.